BRIEF published on 02/03/2026 at 07:05, 3 months 18 days ago Siltronic Meets 2025 Targets Amid Market Challenges Financial Results Market Challenges Siltronic AG 2025 Targets Wafer Industry
BRIEF published on 02/03/2026 at 07:05, 3 months 18 days ago Siltronic atteint ses objectifs pour 2025 malgré les difficultés du marché Résultats Financiers Siltronic AG Défis Du Marché Industrie Des Plaquettes Objectifs Pour 2025
BRIEF published on 02/03/2026 at 07:05, 3 months 18 days ago Sartorius Stedim Biotech enregistre une solide croissance en 2025 EBITDA Biotechnologie Sartorius Croissance 2025 Consommables
BRIEF published on 02/03/2026 at 07:05, 3 months 18 days ago Sartorius Stedim Biotech records strong growth in 2025 EBITDA Biotechnology Sartorius Growth 2025 Consumables
BRIEF published on 02/03/2026 at 07:05, 3 months 18 days ago Medacta Group Reports Remarkable 18.5% Revenue Growth in 2025 Revenue Growth Regional Performance Medacta Group Medical Innovations 2025 Financials
BRIEF published on 02/03/2026 at 07:05, 3 months 18 days ago Le groupe Medacta annonce une croissance remarquable de son chiffre d'affaires de 18,5 % en 2025 Croissance Des Revenus Performance Régionale Groupe Medacta Innovations Médicales Données Financières 2025
BRIEF published on 02/03/2026 at 07:05, 3 months 18 days ago Sartorius Reports Strong Growth and Positive Outlook for 2026 Investment Strategy Bioprocess Solutions 2026 Outlook Financial Results 2025 Sartorius Growth
BRIEF published on 02/03/2026 at 07:05, 3 months 18 days ago Sartorius annonce une forte croissance et des perspectives positives pour 2026 Stratégie D'investissement Solutions De Bioprocédés Résultats Financiers 2025 Perspectives Pour 2026 Croissance De Sartorius
BRIEF published on 02/03/2026 at 07:05, 3 months 18 days ago Newron Pharmaceuticals Highlights Benefits of Evenamide for Schizophrenia Clinical Trials Schizophrenia Newron Pharmaceuticals Evenamide Treatment-resistant
BRIEF published on 02/03/2026 at 07:05, 3 months 18 days ago Newron Pharmaceuticals met en avant les bienfaits de l'Evenamide pour la schizophrénie Essais Cliniques Schizophrénie Newron Pharmaceuticals Evenamide Résistant Au Traitement
Published on 05/21/2026 at 15:00, 4 hours 21 minutes ago Karbon-X Expands Global Energy Attribute Certificate Market Capabilities Amid Growing Renewable Procurement Demand
Published on 05/21/2026 at 14:30, 4 hours 51 minutes ago Rio Grande Resources Advances District-Scale Gold-Silver Target Definition at its Winston Project Through Structural Mapping of Multiple Vein Corridor Systems
Published on 05/21/2026 at 14:00, 5 hours 21 minutes ago Nextech3d.ai to Showcase AI Event Operating System and Krafty Labs Marketplace at Leading EMRG Media Event in New York
Published on 05/21/2026 at 14:00, 5 hours 21 minutes ago Jade Leader Reviews Its Available Critical Minerals Assets
Published on 05/21/2026 at 14:00, 5 hours 21 minutes ago Horizon Aircraft Advances Dual-Use Certification Path Through Cert Center Canada Partnership
Published on 05/21/2026 at 18:26, 54 minutes ago Fuller, Smith & Turner PLC: Transaction in own shares
Published on 05/21/2026 at 18:00, 1 hour 21 minutes ago E-PANGO: Mise en place d’un financement obligataire d’un montant nominal maximum de 4 M€
Published on 05/21/2026 at 17:56, 1 hour 24 minutes ago Annual General Meeting 2026: Adval Tech shareholders approve all proposals
Published on 05/21/2026 at 17:45, 1 hour 36 minutes ago Linedata Services: Assemblée Générale Mixte Modalités de mise à disposition des documents préparatoires
Published on 05/21/2026 at 17:43, 1 hour 37 minutes ago Vonovia SE: AGM approves €1.25 dividend per share and appoints Dr Anne-Marie Großmann-Minkwitz to the Supervisory Board
Published on 05/21/2026 at 17:45, 1 hour 36 minutes ago CEGEDIM: DISCLOSURE OF SHARE CAPITAL AND VOTING RIGHTS
Published on 05/21/2026 at 17:45, 1 hour 36 minutes ago CEGEDIM: DECLARATION D’ACTIONS ET DE DROITS DE VOTE
Published on 05/21/2026 at 16:35, 2 hours 45 minutes ago 260521 BENETEAU Déclaration du nombre d'actions et de droits de vote au 30-04-2026
